FREMONT, Calif., Feb. 14 /PRNewswire-FirstCall/ -- Abgenix, Inc. will announce financial results for the fourth quarter and full year of 2005 on Tuesday, February 21, 2006, after the close of financial markets. Following the announcement, Abgenix will host a conference call at 1:30 p.m. Pacific Time that afternoon to review the company’s financial results.
The live and archived webcasts of the conference call will be available on the Abgenix website, www.abgenix.com. To participate in the conference call, please dial 800-591-6944 fifteen minutes before the conference begins. International callers should dial 617-614-4910. The pass code is 82136361. A telephonic replay of the call will be available by dialing 888-286-8010. International callers should dial 617-801-6888. The replay participant code is 66896648.
About Abgenix
Abgenix is a biopharmaceutical company focused on the discovery, development and manufacturing of human therapeutic antibodies. The company’s antibody development platform includes a leading technology and state-of-the-art manufacturing capabilities that enable the rapid generation, selection and production of high affinity, fully human antibody product candidates to a variety of disease targets. Abgenix leverages its leadership position in human antibody technology to build a diversified product portfolio through the establishment of collaborations with multiple pharmaceutical and biotechnology companies. For more information on Abgenix, visit the company’s website at www.abgenix.com.
Abgenix, Inc.
CONTACT: Greg Mann, Director of Corporate Communications & InvestorRelations of Abgenix, +1-510-284-6566
Web site: http://www.abgenix.com/
